This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Sep 26;381(13):1281-1283.

doi: 10.1056/NEJMe1910754. Epub 2019 Sep 11.

Emerging Use of CRISPR Technology - Chasing the Elusive HIV Cure

Affiliations

Affiliation

¹ From the Center for Cellular Immunotherapies and the Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

PMID: 31509669
DOI: 10.1056/NEJMe1910754

Editorial

Emerging Use of CRISPR Technology - Chasing the Elusive HIV Cure

Carl H June. N Engl J Med. 2019.

. 2019 Sep 26;381(13):1281-1283.

doi: 10.1056/NEJMe1910754. Epub 2019 Sep 11.

Author

Affiliation

¹ From the Center for Cellular Immunotherapies and the Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

PMID: 31509669
DOI: 10.1056/NEJMe1910754

No abstract available

PubMed Disclaimer

Comment on

CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia.
Xu L, Wang J, Liu Y, Xie L, Su B, Mou D, Wang L, Liu T, Wang X, Zhang B, Zhao L, Hu L, Ning H, Zhang Y, Deng K, Liu L, Lu X, Zhang T, Xu J, Li C, Wu H, Deng H, Chen H. Xu L, et al. N Engl J Med. 2019 Sep 26;381(13):1240-1247. doi: 10.1056/NEJMoa1817426. Epub 2019 Sep 11. N Engl J Med. 2019. PMID: 31509667

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.